SEC Form 4 · accession 0001660878-16-000015
VirtualScopics, Inc. · VSCP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Ronald Way
Officer — Chief Operating Officer
Period of report
May 10, 2016
Accepted (ET)
May 12, 2016 · 2:03 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001307752
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock OptionsF1 | $19.90 | May 10, 2016 | D | 5,000 | D | — | Mar 2, 2021 | Common Stock | 5,000 | 0 | D |
| Stock OptionsF1 | $11.30 | May 10, 2016 | D | 750 | D | — | Jan 27, 2022 | Common Stock | 750 | 0 | D |
| Stock OptionsF1 | $4.20 | May 10, 2016 | D | 10,000 | D | — | Aug 19, 2024 | Common Stock | 10,000 | 0 | D |
| Stock OptionsF1 | $3.10 | May 10, 2016 | D | 5,000 | D | — | Jan 28, 2026 | Common Stock | 5,000 | 0 | D |
Explanation of responses
- F1These options which provided for vesting in four equal annual installments beginning on 3/2/11, 1/27/12, 8/19/14 and 1/28/16, respectively, were cancelled pursuant to a Merger Agreement between Issuer and BioTelemetry Research Acquisition Corporation, a wholly-owned subsidiary of BioTelemetry, Inc., in exchange for an amount in cash equal to the product of (A) the positive excess, if any, of (1) the Common Merger Consideration over (2) the exercise price per Common Share then in effect in respect of such stock option, and (B) the aggregate number of Common Shares subject to such stock option immediately prior to the effective time of the merger.